{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:44:39Z","timestamp":1782794679612,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.medcli.2020.07.025","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T06:36:04Z","timestamp":1602138964000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Riesgo cardiometab\u00f3lico en pacientes con hiperaldosteronismo primario y secreci\u00f3n aut\u00f3noma de cortisol. Estudio de casos y controles"],"prefix":"10.1016","volume":"157","author":[{"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Bengoa Rojano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez Arg\u00fceso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Jim\u00e9nez Mendiguch\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Garc\u00eda Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.07.025_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2020.04.029","article-title":"Evidence in favor of medical treatment in primary hyperaldosteronism","author":"Araujo-Castro","year":"2020","journal-title":"Med Clin."},{"key":"10.1016\/j.medcli.2020.07.025_bib0190","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0195","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12020-019-02066-w","article-title":"Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?","volume":"66","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine."},{"key":"10.1016\/j.medcli.2020.07.025_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","article-title":"Autonomous cortisol secretion in adrenal incidentalomas","volume":"64","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine."},{"key":"10.1016\/j.medcli.2020.07.025_bib0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone-cortisol-co-secreting adrenal tumors: The lost subtype of primary aldosteronism","volume":"164","author":"Sp\u00e4th","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0210","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: A large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0220","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.endinu.2020.03.002","article-title":"Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition","volume":"67","author":"Araujo-Castro","year":"2020","journal-title":"Endocrinol Diabetes Nutr."},{"key":"10.1016\/j.medcli.2020.07.025_bib0225","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0230","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.medcli.2020.07.025_bib0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.119.12935","article-title":"Primary aldosteronism","volume":"74","author":"Funder","year":"2019","journal-title":"Hypertension."},{"key":"10.1016\/j.medcli.2020.07.025_bib0240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000336589","article-title":"Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas","volume":"21","author":"Yener","year":"2012","journal-title":"Med Princ Pract."},{"key":"10.1016\/j.medcli.2020.07.025_bib0245","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: A 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0250","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis Pathogenesis, and Treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2020.07.025_bib0255","first-page":"S7","article-title":"Promoting Health in Populations: Standards of Medical Care in Diabetes \u2013- 2020","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"key":"10.1016\/j.medcli.2020.07.025_bib0260","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1055\/s-0035-1565208","article-title":"Glucose Metabolism in Primary Aldosteronism","volume":"47","author":"Remde","year":"2015","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.medcli.2020.07.025_bib0265","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired Glucose Metabolism in Primary Aldosteronism Is Associated with Cortisol Cosecretion","volume":"104","author":"Gerards","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0270","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.medcli.2020.07.025_bib0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.medcli.2020.07.025_bib0280","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40618-014-0232-0","article-title":"Lipid abnormalities in patients with adrenal incidentalomas: Role of subclinical hypercortisolism and impaired glucose metabolism","volume":"38","author":"Masserini","year":"2015","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.medcli.2020.07.025_bib0285","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s00268-015-3197-z","article-title":"Risk of New-Onset Dyslipidemia after Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism","volume":"39","author":"Kaga","year":"2015","journal-title":"World J Surg."},{"key":"10.1016\/j.medcli.2020.07.025_bib0290","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imj.14332","article-title":"Three-year follow up of adrenal incidentalomas in a New Zealand centre","volume":"50","author":"Goh","year":"2020","journal-title":"Intern Med J."},{"key":"10.1016\/j.medcli.2020.07.025_bib0300","first-page":"1440","article-title":"Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0305","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: A systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0310","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: A follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.07.025_bib0315","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension."},{"key":"10.1016\/j.medcli.2020.07.025_bib0320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jch.12914","article-title":"Effects of Treating Primary Aldosteronism on Renal Function","volume":"19","author":"Kramers","year":"2017","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.medcli.2020.07.025_bib0325","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-19-0047","article-title":"Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism","volume":"181","author":"Kawashima","year":"2019","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygcen.2010.07.004","article-title":"Cushing's syndrome, glucocorticoids and the kidney","volume":"169","author":"Smets","year":"2010","journal-title":"Gen Comp Endocrinol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0335","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1113\/jphysiol.2013.267609","article-title":"Glucocorticoids and renal Na+ transport: Implications for hypertension and salt sensitivity","volume":"592","author":"Hunter","year":"2014","journal-title":"J Physiol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0340","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11\u03b2-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.07.025_bib0345","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/iju.14205","article-title":"Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome","volume":"27","author":"Nakamura","year":"2020","journal-title":"Int J Urol."},{"key":"10.1016\/j.medcli.2020.07.025_bib0350","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/a-0630-1397","article-title":"Could Lipid Profile be Used as a Marker of Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas?","volume":"50","author":"Mintziori","year":"2018","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.medcli.2020.07.025_bib0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","article-title":"Worsening of lipid metabolism after successful treatment of primary aldosteronism","volume":"54","author":"Adolf","year":"2016","journal-title":"Endocrine."},{"key":"10.1016\/j.medcli.2020.07.025_bib0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320306278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320306278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:53:20Z","timestamp":1758419600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320306278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0025775320306278"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.07.025","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riesgo cardiometab\u00f3lico en pacientes con hiperaldosteronismo primario y secreci\u00f3n aut\u00f3noma de cortisol. Estudio de casos y controles","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}